SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056998
Filing Date
2024-05-09
Accepted
2024-05-09 16:15:44
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lctx-20240331.htm   iXBRL 10-Q 1614313
2 EX-10.1 lctx-ex10_1.htm EX-10.1 18347
3 EX-10.2 lctx-ex10_2.htm EX-10.2 18302
4 EX-10.3 lctx-ex10_3.htm EX-10.3 18349
5 EX-31.1 lctx-ex31_1.htm EX-31.1 13492
6 EX-31.2 lctx-ex31_2.htm EX-31.2 12231
7 EX-32.1 lctx-ex32_1.htm EX-32.1 9464
  Complete submission text file 0000950170-24-056998.txt   8056588

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lctx-20240331.xsd EX-101.SCH 1290804
80 EXTRACTED XBRL INSTANCE DOCUMENT lctx-20240331_htm.xml XML 1335813
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 24930878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)